about
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.Identification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells.ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.Insulin-like Growth Factor 2 Overexpression Induces β-Cell Dysfunction and Increases Beta-cell Susceptibility to Damage.AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistanceBeta cell expression of IGF-I leads to recovery from type 1 diabetes.Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease.AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease.Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of β-cell mass.Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance.In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9.Anti-inflammatory action of type I interferons deduced from mice expressing interferon beta.IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice.FGF21 gene therapy as treatment for obesity and insulin resistanceAltered glucose-stimulated insulin secretion in a mouse line with activated polyamine catabolismVitamin D Receptor overexpression in β-cells ameliorates diabetes in miceVascular Interstitial Cells in Retinal Arteriolar Annuli Are Altered During Hypertension
P50
Q33836234-6C44221F-3E02-4A79-8F0B-26D0A97CBB3AQ35874596-C1A7364D-730D-4133-AEFC-591BC6C36713Q38864493-61728B7F-FA22-46BC-88A7-293520435719Q38875279-4928A835-E09E-4114-9983-78989E1D7A2CQ39137705-D7560CDD-8C01-4D3C-BE2C-57F77E4D570BQ39737833-D5812387-9D20-4E53-99B4-415CD70FD495Q40716676-B926E64D-DBF1-4D36-A0DE-55DC4FAC137AQ40753351-377DFCE9-CF0E-4DFC-BE93-E47737FF8C29Q42085309-41A63B3B-369F-456B-99D0-DC066DF35138Q42409734-F21B056E-74B9-4FFC-825E-3FF92E2022B3Q42518071-7C98F493-245B-440A-B65B-A1BE97DCDF06Q45867072-38D8EA4A-A5CA-49AB-8DAF-8229BB7C4535Q45868391-8863DE2C-181D-473E-8260-4AB758C1BFBAQ45879291-96FEB14D-9A0E-45AD-BE08-047FDBC61979Q57688659-50CF76D8-2A99-462A-A900-0BF0582B2349Q83014631-977DEAD1-35D9-4A07-A886-E408CDD33103Q89837614-52D74E4D-5083-47E2-89A7-0A4AE4544479Q91303402-FFC91AF5-F8CF-44EE-A44E-15C2988CDB17
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0203-4733
@en
name
Alba Casellas
@ast
Alba Casellas
@en
Alba Casellas
@es
Alba Casellas
@nl
type
label
Alba Casellas
@ast
Alba Casellas
@en
Alba Casellas
@es
Alba Casellas
@nl
prefLabel
Alba Casellas
@ast
Alba Casellas
@en
Alba Casellas
@es
Alba Casellas
@nl
P108
P106
P31
P496
0000-0003-0203-4733